PGT-A Testing: A New hope for Women Over 35 Seeking IVF Success
For women over 35, the journey to conception via In Vitro Fertilization (IVF) can be emotionally and physically demanding. Repeated cycles, unsuccessful implantations, and the heartbreak of miscarriage are unfortunately common. Though, a recent trial offers a promising advancement: preimplantation genetic testing for aneuploidy (PGT-A). This testing could substantially improve your chances of a accomplished pregnancy and a healthy baby.
Understanding Aneuploidy and Its Impact
Aneuploidy refers to an abnormal number of chromosomes in a cell. Typically, human cells have 46 chromosomes arranged in 23 pairs. When cells have missing or extra chromosomes, it’s considered aneuploidy. this condition is a leading cause of:
Miscarriage
Birth defects
Genetic conditions like Down syndrome
As you age, the quality of your eggs naturally declines, increasing the risk of aneuploidy in developing embryos. This is why women over 35 frequently enough face greater challenges with IVF.
How PGT-A works
PGT-A involves testing embryos created through IVF before they are implanted in the uterus. Here’s a breakdown of the process:
- Embryo Creation: Eggs are fertilized with sperm in a lab.
- Biopsy: A few cells are carefully removed from each embryo. This doesn’t harm the developing embryo.
- Genetic Analysis: These cells are screened for the correct number of chromosomes.
- Selection: Embryos with a normal chromosome count (euploid embryos) are selected for transfer.
Trial Results: Faster Pregnancy, Higher Success Rates
A recent trial conducted at King’s Fertility, involving 100 women aged 35-42, demonstrated the benefits of PGT-A. The results were compelling:
Fewer IVF Cycles: Women who underwent PGT-A achieved pregnancy in fewer attempts.
Increased Live Birth Rate: The PGT-A group experienced a 72% live birth rate after up to three embryo transfers, compared to 52% in the group without testing.
These findings suggest that PGT-A can significantly improve the efficiency of IVF for women in this age group.
Reducing the Emotional Toll of IVF
The emotional burden of repeated IVF failures is ample. PGT-A offers a way to potentially reduce this stress by:
increasing the likelihood of a successful implantation.
Minimizing the risk of miscarriage.
shortening the time it takes to achieve pregnancy.
“Our findings suggest that targeted use of PGT-A in this age group could help more women have a baby sooner, while also reducing the emotional toll of repeated unsuccessful cycles,” explains Dr. Yusuf Beebeejaun of King’s Collage London and King’s Fertility.
What Does This Mean for You?
If you are over 35 and considering IVF, discussing PGT-A with your fertility specialist is crucial. While larger trials are needed to confirm these results,the current evidence points to a valuable tool for improving your chances of a healthy pregnancy.Dr. Sesh Sunkara, also of King’s College London and king’s Fertility, emphasizes the potential benefits: “Improving treatment efficiency with a shorter time to achieving pregnancy and live birth could reduce the physical and emotional burden of IVF for women of advanced reproductive age.”
further Reading: You can find more information on the effects of vaping on children in a recent study here.
Related reading